Cargando…

Expression of FOXM1 and PLK1 predicts prognosis of patients with hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is one of the most frequently encountered malignant tumor types and to improve its treatment, effective prognostic biomarkers are urgently required. Cell cycle dysregulation is a significant feature of cancer progression. The aim of the present study was to estimate th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fan, Weiqiang, Ma, Huan, Jin, Bin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2022
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8941521/ https://www.ncbi.nlm.nih.gov/pubmed/35350587 http://dx.doi.org/10.3892/ol.2022.13266

Ejemplares similares

A gene expression signature of FOXM1 predicts the prognosis of hepatocellular carcinoma
por: Song, Bic-Na, et al.
Publicado: (2018)

Expression of FOXM1 and Aurora-A predicts prognosis and sorafenib efficacy in patients with hepatocellular carcinoma
por: Su, Wen-Lung, et al.
Publicado: (2020)

The FOXM1-PLK1 axis is commonly upregulated in oesophageal adenocarcinoma
por: Dibb, M, et al.
Publicado: (2012)

Expression of FSCN1 and FOXM1 are associated with poor prognosis of adrenocortical carcinoma patients
por: Liang, Jiayu, et al.
Publicado: (2019)

From imaging to clinical outcome: dual-region CT radiomics predicting FOXM1 expression and prognosis in hepatocellular carcinoma
por: Chen, Xianyu, et al.
Publicado: (2023)

FOXM1c is the predominant FOXM1 isoform expressed in cholangiocarcinoma that associated with metastatic potential and poor prognosis of patients
por: Klinhom-on, Nathakan, et al.
Publicado: (2021)

Plk1 Regulates the Repressor Function of FoxM1b by inhibiting its Interaction with the Retinoblastoma Protein
por: Mukhopadhyay, Nishit K., et al.
Publicado: (2017)

Overexpression of FoxM1 predicts poor prognosis of intrahepatic cholangiocarcinoma
por: Liu, Lingyun, et al.
Publicado: (2018)

FOXM1 promotes hepatocellular carcinoma progression by regulating KIF4A expression
por: Hu, Guohui, et al.
Publicado: (2019)

Participation of PLK1 and FOXM1 in the hyperplastic proliferation of pulmonary artery smooth muscle cells in pulmonary arterial hypertension
por: Wilson, Jamie L., et al.
Publicado: (2019)

FOXM1-induced TYMS upregulation promotes the progression of hepatocellular carcinoma
por: Wang, Liang, et al.
Publicado: (2022)

Author Correction: Plk1 Regulates the Repressor Function of FoxM1b by inhibiting its Interaction with the Retinoblastoma Protein
por: Mukhopadhyay, Nishit K., et al.
Publicado: (2018)

Invasive FoxM1 phosphorylated by PLK1 induces the polarization of tumor-associated macrophages to promote immune escape and metastasis, amplified by IFITM1
por: Xu, Rong, et al.
Publicado: (2023)

CDC2 Is an Important Driver of Vascular Smooth Muscle Cell Proliferation via FOXM1 and PLK1 in Pulmonary Arterial Hypertension
por: Pal-Ghosh, Ruma, et al.
Publicado: (2021)

Correction: FOXM1-induced TYMS upregulation promotes the progression of hepatocellular carcinoma
por: Wang, Liang, et al.
Publicado: (2022)

Overexpressed FOXM1 collaborates with MMB to increase WEE1 inhibitor sensitivity in NSCLC
por: Tan, Jian, et al.
Publicado: (2023)

Knockdown of actin-like 8 inhibits cell proliferation by regulating FOXM1, STMN1, PLK1, and BIRC5 in lung adenocarcinoma A549 cells
por: Ma, Shanwu, et al.
Publicado: (2019)

Clinicopathological and prognostic significance of FoxM1 in hepatocellular carcinoma patients: a meta-analysis
por: Liang, Chaojie, et al.
Publicado: (2018)

FoxM1 promotes epithelial-mesenchymal transition of hepatocellular carcinoma by targeting Snai1
por: Yu, Chun-Peng, et al.
Publicado: (2017)

Increased FOXM1 Expression was Associated with the Prognosis and the Recruitment of Neutrophils in Endometrial Cancer
por: Chen, Jing, et al.
Publicado: (2023)

The expression of PLK-1 in cervical carcinoma: a possible target for enhancing chemosensitivity
por: Zhang, Yuan, et al.
Publicado: (2009)

PLK1 as one novel target for the poor prognosis of bladder cancer: An observational study
por: Liu, Bin, et al.
Publicado: (2022)

The expression and clinical significance of PLK1/p-PLK1 protein in NK/T cell Lymphoma
por: Zhang, Zhiqi, et al.
Publicado: (2023)

FOXM1-Mediated LINC-ROR Regulates the Proliferation and Sensitivity to Sorafenib in Hepatocellular Carcinoma
por: Zhi, Yingru, et al.
Publicado: (2019)

Prognostic significance of FOXM1 expression and antitumor effect of FOXM1 inhibition in synovial sarcomas
por: Maekawa, Akira, et al.
Publicado: (2016)

Overexpression of Taspase 1 Predicts Poor Prognosis in Patients with Hepatocellular Carcinoma
por: Jiang, Jie, et al.
Publicado: (2021)

Investigation of Functional Synergism of CENPF and FOXM1 Identifies POLD1 as Downstream Target in Hepatocellular Carcinoma
por: Ho, Daniel Wai-Hung, et al.
Publicado: (2022)

Low expression or hypermethylation of PLK2 might predict favorable prognosis for patients with glioblastoma multiforme
por: Xia, Xiangping, et al.
Publicado: (2019)

High expression of GFAT1 predicts unfavorable prognosis in patients with hepatocellular carcinoma
por: Li, Lili, et al.
Publicado: (2017)

Dasatinib synergises with irinotecan to suppress hepatocellular carcinoma via inhibiting the protein synthesis of PLK1
por: Xu, Li, et al.
Publicado: (2017)

FOXM1: Functional Roles of FOXM1 in Non-Malignant Diseases
por: Zhang, Zhenwang, et al.
Publicado: (2023)

Clinicopathological Significance of AKT1 and PLK1 Expression in Oral Squamous Cell Carcinoma
por: Sun, Er-Can, et al.
Publicado: (2022)

Prognostic Significance of Forkhead Box M1 (FOXM1) Expression and Antitumor Effect of FOXM1 Inhibition in Angiosarcoma
por: Ito, Takamichi, et al.
Publicado: (2016)

Inhibition of polo-like kinase 1 (PLK1) facilitates reactivation of gamma-herpesviruses and their elimination
por: Biswas, Ayan, et al.
Publicado: (2021)

Overexpression of FOXM1 is associated with metastases of nasopharyngeal carcinoma
por: Jiang, Lizhu, et al.
Publicado: (2014)

FOXM1 Is a Novel Molecular Target of AFP-Positive Hepatocellular Carcinoma Abrogated by Proteasome Inhibition
por: Li, Ru, et al.
Publicado: (2022)

Combination of FOXD1 and Plk2: A novel biomarker for predicting unfavourable prognosis of colorectal cancer
por: Zong, Yaping, et al.
Publicado: (2022)

Overexpression of RALY promotes migration and predicts poor prognosis in hepatocellular carcinoma
por: Zhu, Zebin, et al.
Publicado: (2018)

Co-expression of LASS2 and TGF-β1 predicts poor prognosis in hepatocellular carcinoma
por: Ruan, Haoyu, et al.
Publicado: (2016)

ESPL1 is Elevated in Hepatocellular Carcinoma and Predicts Prognosis
por: Song, Rui, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1ijlq3eichtg9pqd7oa0akaumt